The UK’s Institute of Cancer Research (ICR) has installed ACD/Spectrus Processor from ACD/Labs in its research programs to simplify processing and analysis of chromatography, mass spectrometry, and NMR data. More than 40 medicinal chemists work at the ICR within drug discovery programs with the aim of developing chemotherapeutic drug candidates, using analytical chemistry techniques to study and characterise novel chemical entities.
Prior to this deployment, the ICR relied on a number of different software programs to manage its analytical data. With ACD/Spectrus Processor, that data is unified into one environment, which enables scientists to reach decisions faster, simplify data preparation for reporting and publication, and eliminate the burden of technical training and IT support.
‘We provide our medicinal chemists with a dozen LC/MS, LC/UV, and NMR instruments from various vendors including Agilent, Bruker, Gilson, Thermo, and Waters,’ said Dr Amin Mirza, head of Structural Chemistry at the Cancer Research UK Cancer Therapeutics Unit at the Institute of Cancer Research. ‘Using one tool to process and analyse all this data, instead of a suite of five or more, will certainly streamline the efforts of my group.’
ACD/Spectrus Processor is the foundation product of the ACD/Spectrus Platform, which delivers multi-technique, vendor-agnostic data processing and interpretation, reporting and knowledge management into one uniform informatics environment.
